Compositions and methods for treating ischemic heart disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 20, 2021
Grant Date -
Oct 24, 2019
app pub date -
Jul 10, 2019
filing date -
Dec 17, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present disclosure is directed to the treatment of ischemic heart disease and clinical conditions associated with ischemic heart disease. A composition containing a monoclonal antibody directed against gastric inhibitory polypeptide is administered. This results in cardioprotective effects against acute myocardial infarction, such as a decrease in circulating triglycerides, total cholesterol, and low-density lipoproteins, and an increase in the ratio of high-density lipoprotein to total cholesterol.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully